← Leaderboards
F. Patrick Ross
Barnes-Jewish Hospital
$4,287,010
Attributed
$4,287,010
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $796.3K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$4,287,010 · 6
By mechanism
R01$3,907,353 · 2
R21$363,651 · 1
P41$16,006 · 3
Top collaborators
No co-investigators on record.
Most similar at Barnes-Jewish Hospital
Same institution · by research overlap
- Philip A Osdoby$2,596,136
- Gregory M Lanza$17,053,599
- Roberto Civitelli$15,701,535
- Steven R Mumm$2,917,246
- Deborah V Novack$11,807,146
Others in their field
Top investigators on “Osteoclasts”
- Brendan Hl Lee · Baylor College Of Medicine$18,789,257
- Steven L Teitelbaum · Washington University$16,498,459
- Mone Zaidi · Icahn School Of Medicine At Mount Sinai$16,089,949
- Karl Leonard Insogna · Yale University$15,344,415
- Yi-Ping Li · Tulane University Of Louisiana$14,733,549
- Yongwon Choi · University Of Pennsylvania$14,421,139
Research focus
OsteoclastsBiological Signal TransductionPhosphorylationTyrosineCell DifferentiationColony Stimulating FactorTissue /Cell CultureMediatingMindLaboratory MouseOsteoporosisFibroblastsCellsProtein Structure FunctionCell TypeCell ProliferationHigh Performance Liquid ChromatographyDisease /Disorder Prevention /ControlDrug Adverse EffectAnimaliaCathepsin KAntiaids AgentBone ResorptionComputer Retrieval Of Information On Scientific Projects Database
Grant awards (19)
PROTEOMICS OF REGULATED EXOCYTOSIS IN OSTEOCLASTS$8,730
P41 · FY2009 · RR · contact PI
M-CSF Signaling in Osteoclast Formation and Function$258,751
R01 · FY2008 · AR · contact PI
M-CSF SIGNALLING IN OSTEOCLAST FORMATION AND FUNCTION$5,991
P41 · FY2008 · RR · contact PI
PROTEOMICS OF REGULATED EXOCYTOSIS IN OSTEOCLASTS$1,285
P41 · FY2008 · RR · contact PI
M-CSF Signaling in Osteoclast Formation and Function$264,031
R01 · FY2007 · AR · contact PI
PROTEOMICS OF REGULATED EXOCYTOSIS IN OSTEOCLASTS$162,351
R21 · FY2007 · AR · contact PI
Bone Loss and Its Prevention in HIV Patients$323,087
R01 · FY2006 · AR · contact PI
M-CSF Signaling in Osteoclast Formation and Function$271,916
R01 · FY2006 · AR · contact PI
PROTEOMICS OF REGULATED EXOCYTOSIS IN OSTEOCLASTS$201,300
R21 · FY2006 · AR · contact PI
Bone Loss and Its Prevention in HIV Patients$330,863
R01 · FY2005 · AR
M-CSF Signaling in Osteoclast Formation and Function$278,460
R01 · FY2005 · AR
Bone Loss and Its Prevention in HIV Patients$351,325
R01 · FY2004 · AR
M-CSF Signaling in Osteoclast Formation and Function$278,460
R01 · FY2004 · AR
Bone Loss and Its Prevention in HIV Patients$351,325
R01 · FY2003 · AR
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTION$222,615
R01 · FY2003 · AR
Bone Loss and Its Prevention in HIV Patients$347,370
R01 · FY2002 · AR
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTION$202,461
R01 · FY2002 · AR
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTION$215,340
R01 · FY2001 · AR
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTION$211,349
R01 · FY2000 · AR